Jiaqi Chai

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Peritoneal Dialysis

Induced Apoptosis

Peripheral Blood

Patient Reported Outcomes

Top Venues

Journal of cancer research and clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Shuhan Zhang, Luyang Li, Cheng-Li Liu, Meng Pu, Yingbo Ma, Tao Zhang, Jiaqi Chai, Haoming Li, Jun Yang, Meishan Chen, Ling-Hong Kong, Tian Xia
The use of peripheral CD3 + γδ + Vδ2 + T lymphocyte cells in combination with the ALBI score to predict immunotherapy response in patients with advanced hepatocellular carcinoma: a retrospective study. Journal of cancer research and clinical oncology 150 (7) (2024)
Shuhan Zhang, Luyang Li, Cheng-Li Liu, Meng Pu, Yingbo Ma, Tao Zhang, Jiaqi Chai, Haoming Li, Jun Yang, Meishan Chen, Ling-Hong Kong, Tian Xia
The use of peripheral CD3 + γδ + Vδ2 + T lymphocyte cells in combination with the ALBI score to predict immunotherapy response in patients with advanced hepatocellular carcinoma: a retrospective study. Journal of cancer research and clinical oncology 150 (7) (2024)
Shuhan Zhang, Luyang Li, Cheng-Li Liu, Meng Pu, Yingbo Ma, Tao Zhang, Jiaqi Chai, Haoming Li, Jun Yang, Meishan Chen, Ling-Hong Kong, Tian Xia
The use of peripheral CD3 + γδ + Vδ2 + T lymphocyte cells in combination with the ALBI score to predict immunotherapy response in patients with advanced hepatocellular carcinoma: a retrospective study. Journal of cancer research and clinical oncology 150 (7) (2024)